<DOC>
	<DOCNO>NCT02096419</DOCNO>
	<brief_summary>The purpose study determine whether continuous clopidogrel dose adjustment target platelet function test improves outcomes 12 month follow-up acute coronary syndrome patient treat coronary artery stenting determine high platelet reactivity clopidogrel .</brief_summary>
	<brief_title>Continuous Clopidogrel Dose Adjustment Acute Coronary Syndrome Patients With High On-treatment Platelet Reactivity</brief_title>
	<detailed_description>Dual antiplatelet therapy ( DAPT ) aspirin P2Y12 receptor antagonists 12 month present cornerstone treatment acute coronary syndrome ( ACS ) patient undergo percutaneous coronary intervention ( PCI ) . Clopidogrel widely use P2Y12 inhibitor despite 's limitation include highly variable P2Y12-receptor inhibition cause wide interindividual platelet reactivity variability . Since high on-treatment platelet reactivity ( HTPR ) clopidogrel strongly associate adverse event , antiplatelet therapy tailor vastly investigate determine whether individualized approach could improve outcome . In time progressive personalize approach therapy , effective strategy need minimize risk ischemic adverse event without increase risk bleeding . Aim study investigate whether continuous clopidogrel dose adjustment accord platelet function test ( PFT ) use Multiplate® function analyzer ( Roche Diagnostics , Mannheim , Germany ) could decrease rate adverse event ACS patient treat PCI HTPR early late period DAPT treatment . Cut value HTPR enhance platelet response set accord consensus statement &gt; 46 U &lt; 19 U , respectively . PFT therapy tailor perform day 1 , 2 , 3 , 7 , 30 month 2 , 3 , 6 , 9 12 .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>acute coronary syndrome patient treat successful PCI age 1880 year determine high ontreatment platelet reactivity continuous postinterventional glycoprotein ( GP ) IIbIIIa receptor inhibitor infusion thrombocytopenia ( &lt; 150x109/L ) significant renal insufficiency ( creatinine &gt; 200 µmol/L ) anemia ( Htc &lt; 30 % ) hemorrhagic diathesis history intracranial bleeding ischemic cerebrovascular insult 6 month major operation 6 week concomitant chronic anticoagulation therapy age &lt; 18 year &gt; 80 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>clopidogrel</keyword>
	<keyword>platelet reactivity</keyword>
	<keyword>acute coronary syndrome</keyword>
	<keyword>tailor therapy</keyword>
	<keyword>outcome</keyword>
</DOC>